Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and akt-dependent mechanisms

Journal of the American College of Cardiology

Volumn 63, Issue 24, 2014, Pages 2722-2733

  Kataoka, Yoshiyuki ^a   Shibata, Rei ^a   Ohashi, Koji ^a   Kambara, Takahiro ^a   Enomoto, Takashi ^a   Uemura, Yusuke ^a   Ogura, Yasuhiro ^a   Yuasa, Daisuke ^a   Matsuo, Kazuhiro ^a   Nagata, Takanobu ^b   Oba, Toyoharu ^b   Yasukawa, Hideo ^b   Numaguchi, Yasushi ^a   Sone, Takahito ^c   Murohara, Toyoaki ^a   Ouchi, Noriyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

apoptosis; ischemia; myocytes; omentin; reperfusion

Indexed keywords

ADENOVIRUS VECTOR; ADIPOCYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OMENTIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ACUTE HEART INFARCTION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HEART CELL CULTURE; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC THERAPY; ADULT; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

APOPTOSIS; ISCHEMIA; MYOCYTES; OMENTIN; REPERFUSION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; ONCOGENE PROTEIN V-AKT; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHORYLATION;

EID: 84902602873     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.032     Document Type: Article

References (41)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. R. Wolk, P. Berger, R.J. Lennon, E.S. Brilakis, and V.K. Somers Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease Circulation 108 2003 2206 2211
3. P.R. Orlander, D.C. Goff, and M. Morrissey et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project Diabetes 43 1994 897 902
4. S.L. Woodfield, C.F. Lundergan, and J.S. Reiner et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience J Am Coll Cardiol 28 1996 1661 1669
5. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat Rev Immunol 11 2011 85 97
6. R.Z. Yang, M.J. Lee, and H. Hu et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol Endocrinol Metab 290 2006 E1253 E1261
7. S. Tsuji, J. Uehori, and M. Matsumoto et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall J Biol Chem 276 2001 23456 23463
8. C.M. de Souza Batista, R.Z. Yang, and M.J. Lee et al. Omentin plasma levels and gene expression are decreased in obesity Diabetes 56 2007 1655 1661
9. H.Y. Pan, L. Guo, and Q. Li Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes Diabetes Res Clin Pract 88 2010 29 33
10. R. Shibata, R. Takahashi, and Y. Kataoka et al. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men Hypertens Res 34 2011 1309 1312
11. R. Shibata, N. Ouchi, and R. Takahashi et al. Omentin as a novel biomarker of metabolic risk factors Diabetol Metab Syndr 4 2012 37
12. H.O. El-Mesallamy, M.O. El-Derany, and N.M. Hamdy Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease Diabet Med 28 2011 1194 1200
13. F.J. Shang, J.P. Wang, and X.T. Liu et al. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome Biomarkers 16 2011 657 662
14. R. Shibata, N. Ouchi, and R. Kikuchi et al. Circulating omentin is associated with coronary artery disease in men Atherosclerosis 219 2011 811 814
15. I. Onur, F. Oz, and S. Yildiz et al. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women Angiology 2013 Nov 21 [E-pub ahead of print]
16. H. Yamawaki, N. Tsubaki, M. Mukohda, M. Okada, and Y. Hara Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels Biochem Biophys Res Commun 393 2010 668 672
17. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, and Y. Hara Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells Biochem Biophys Res Commun 408 2011 339 343
18. S. Maruyama, R. Shibata, and R. Kikuchi et al. Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism J Biol Chem 287 2012 408 417
19. S. Greulich, W.J. Chen, and B. Maxhera et al. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies PLoS One 8 2013 e59697
20. R. Shibata, Y. Numaguchi, and K. Matsushita et al. Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction Am J Cardiol 101 2008 1712 1715
21. R. Shibata, K. Sato, and D.R. Pimentel et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103
22. T. Kambara, K. Ohashi, and R. Shibata et al. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism J Biol Chem 287 2012 18965 18973
23. E.J. Miller, J. Li, and L. Leng et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart Nature 451 2008 578 582
24. R.R. Russell 3rd, J. Li, and D.L. Coven et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 2004 495 503
25. Y. Fujio, T. Nguyen, D. Wencker, R.N. Kitsis, and K. Walsh Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 2000 660 667
26. J.W. Calvert, S. Gundewar, and S. Jha et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling Diabetes 57 2008 696 705
27. M. Laser, C.D. Willey, and W. Jiang et al. Integrin activation and focal complex formation in cardiac hypertrophy J Biol Chem 275 2000 35624 35630
28. U. Boltzen, A. Eisenreich, and S. Antoniak et al. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-alpha-induced apoptosis J Mol Cell Cardiol 52 2012 1056 1065
29. J.W. Elrod, J.W. Calvert, S. Gundewar, N.S. Bryan, and D.J. Lefer Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide Proc Natl Acad Sci U S A 105 2008 11430 11435
30. J.P. Aragon, M.E. Condit, and S. Bhushan et al. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation J Am Coll Cardiol 58 2011 2683 2691
31. Y. Onai, J. Suzuki, and T. Kakuta et al. Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury Cardiovasc Res 63 2004 51 59
32. H. Ling, C.B. Gray, and A.C. Zambon et al. Ca2+/calmodulin-dependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB Circ Res 112 2013 935 944
33. T. Komiya, Y. Tanigawa, and S. Hirohashi Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice Biochem Biophys Res Commun 251 1998 759 762
34. W.R. MacLellan, and M.D. Schneider Death by design. Programmed cell death in cardiovascular biology and disease Circ Res 81 1997 137 144
35. A. Abbate, R. Bussani, M.S. Amin, G.W. Vetrovec, and A. Baldi Acute myocardial infarction and heart failure: role of apoptosis Int J Biochem Cell Biol 38 2006 1834 1840
36. C. Gill, R. Mestril, and A. Samali Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J 16 2002 135 146
37. Y. Ogura, N. Ouchi, and K. Ohashi et al. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models Circulation 126 2012 1728 1738
38. S. Negoro, H. Oh, and E. Tone et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction Circulation 103 2001 555 561
39. X. Zhong, X. Li, F. Liu, H. Tan, and D. Shang Omentin inhibits TNF-alpha-induced expression of adhesion molecules in endothelial cells via ERK/NF-kappaB pathway Biochem Biophys Res Commun 425 2012 401 406
40. S. Tsuji, M. Yamashita, and A. Nishiyama et al. Differential structure and activity between human and mouse intelectin-1: human intelectin-1 is a disulfide-linked trimer, whereas mouse homologue is a monomer Glycobiology 17 2007 1045 1051
41. X. Zhong, H.Y. Zhang, and H. Tan et al. Association of serum omentin-1 levels with coronary artery disease Acta Pharmacol Sin 32 2011 873 878